France vs Slovenia: Cause of death, by non-communicable diseases, ages 15-59
France
76.3%
in 2021
Slovenia
76.4%
in 2021
France rank
19th
Slovenia rank
18th
Cause of death, by non-communicable diseases, ages 15-59 over time
- France
- Slovenia
How they compare
Slovenia currently reports 76.4% against 76.3% in France, a difference of 0.1%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was France ahead.
France ranks 19th and Slovenia ranks 18th of 185 countries.
Across the 3 decades both report, France averaged higher in 1 and Slovenia in 2.
Head to head by decade
| Decade | France | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.9% | 73.7% | 0.2% | France |
| 2010s | 78.5% | 78.9% | 0.4% | Slovenia |
| 2020s | 75.9% | 76.9% | 1.0% | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, France or Slovenia?
- Slovenia, at 76.4% against 76.3% in France as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between France and Slovenia?
- 0.1%, with Slovenia ahead.
- How many years of comparable data are there for France and Slovenia?
- 6 years are reported by both, from 2000 to 2021.
- How do France and Slovenia rank globally for cause of death, by non-communicable diseases, ages 15-59?
- France ranks 19th and Slovenia ranks 18th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.